Best Value Stocks to Buy for March 4th

Here are two stocks with buy rank and strong value characteristics for investors to consider today, March 4th:  

Catalyst Pharmaceuticals CPRX: This commercial-stage biopharmaceutical company, which is focused on the development and commercialization of therapies targeting rare and difficult-to-treat diseases, carries a Zacks Rank #1 (Strong Buy), and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 2% over the last 60 days.

Catalyst Pharmaceuticals, Inc. Price and Consensus

Catalyst Pharmaceuticals, Inc. price-consensus-chart | Catalyst Pharmaceuticals, Inc. Quote

Catalyst Pharmaceuticals has a price-to-earnings ratio (P/E) of 8.49 compared with 22.04 for the S&P. The company possesses a Value Score of A.

Catalyst Pharmaceuticals, Inc. PE Ratio (TTM)

Catalyst Pharmaceuticals, Inc. pe-ratio-ttm | Catalyst Pharmaceuticals, Inc. Quote

XP XP: This technology-driven financial services platform, which offers financial products and services primarily in Brazil, carries a Zacks Rank #1, and has witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.7% over the last 60 days.

XP Inc. Price and Consensus

XP Inc. price-consensus-chart | XP Inc. Quote

XP has a price-to-earnings ratio (P/E) of 10.06 compared with 22.04 for the S&P. The company possesses a Value Score of A.

XP Inc. PE Ratio (TTM)

XP Inc. pe-ratio-ttm | XP Inc. Quote

See the full list of top ranked stocks here.

Learn more about the Value score and how it is calculated here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research